Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;26(5):404-12.
doi: 10.1097/QCO.0b013e3283638104.

Brucellosis in low-income and middle-income countries

Matthew P Rubach  1 , Jo E B Halliday, Sarah Cleaveland, John A Crump
Affiliations
Review

Brucellosis in low-income and middle-income countries

Matthew P Rubach et al. Curr Opin Infect Dis. 2013 Oct.

Abstract

Purpose of review: Human brucellosis is a neglected, underrecognized infection of widespread geographic distribution. It causes acute febrile illness and a potentially debilitating chronic infection in humans, and livestock infection has substantial socioeconomic impact. This review describes new information regarding the epidemiology of brucellosis in the developing world and advances in diagnosis and treatment.

Recent findings: The highest recorded incidence of human brucellosis occurs in the Middle East and Central Asia. Fever etiology studies demonstrate brucellosis as a cause of undifferentiated febrile illness in the developing world. Brucellosis is a rare cause of fever among returning travelers, but is more common among travelers returning from the Middle East and North Africa. Sensitive and specific rapid diagnostic tests appropriate for resource-limited settings have been validated. Randomized controlled trials demonstrate that optimal treatment for human brucellosis consists of doxycycline and an aminoglycoside. Decreasing the burden of human brucellosis requires control of animal brucellosis, but evidence to inform the design of control programs in the developing world is needed.

Summary: Brucellosis causes substantial morbidity in human and animal populations. While improvements in diagnostic options for resource-limited settings and stronger evidence for optimal therapy should enhance identification and treatment of human brucellosis, prevention of human disease through control in animals remains paramount.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Corbel MJ. Brucellosis in humans and animals. Geneva: WHO; 2006. [Accessed 28 March 2013]. http://www.who.int/csr/resources/publications/Brucellosis.pdf.
    1. Bruce D. Note on the discovery of a micro-organism in Malta fever. Practitioner. 1887;39:161–170.
    1. Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010;36 (Suppl 1):S8–S11. - PubMed
    1. Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14:e469–e478. - PubMed
    1. Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1929. This meta-analysis gives a comprehensive summation of clinical manifestations of human brucellosis, and the disability weights for brucellosis presented in this study represent an important step toward estimating the burden of disease due to brucellosis. - PMC - PubMed

Publication types